Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic & Translational

Utilizing FDG-PET/CT to Assess Radiation-induced Cardiotoxicity in Patients with Lung Cancer Based on Tumor Location

Raheleh Taghvaei, Reza Sirous, Alexandra Dreyfuss, Thomas Werner and Abass Alavi
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1314;
Raheleh Taghvaei
2University of Pennsylvania Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reza Sirous
1Nuclear Medicine Baltimore MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandra Dreyfuss
2University of Pennsylvania Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Werner
2University of Pennsylvania Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abass Alavi
2University of Pennsylvania Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1314

Objectives: Radiation therapy (RT) has been established as a highly effective treatment for locally advanced lung cancer. However, radiation-related cardiotoxicity is a risk associated with chest RT that can limit the utilization of RT. Several studies have shown increases in cardiovascular injury and mortality with increasing doses of RT in patients with lung cancer. However, the risk of cardiotoxicity based on the site of the lung tumor has been studied to a lesser extent. FDG-PET/CT, with its unique capability to detect metabolic activity of various tissues, can be utilized to identify post-RT cardiac injury in subclinical and clinical stages. In this study, we aimed to evaluate RT-related cardiotoxicity in lung cancer patients based on tumor location by analyzing FDG PET/CT images pre- and post-RT. Methods: We evaluated 65 patients with inoperable stage II and stage III non-small cell lung cancer (NSCLC) with no distant metastasis (American College of Radiology Imaging Network (ACRIN); NCT00083083). The patients received daily thoracic RT of 1.8-2.0 Gy, up to a total dose of at least 60 Gy, with concurrent platinum-based doublet chemotherapy. FDG-PET/CT scans were performed before and 5-6 months after RT. Images were analyzed by OsiriX MD software (Pixmeo SARL, Bernex, Switzerland). The regions of interests were placed on all the axial slices of the heart from the base to the apex. The global cardiac mean standardized uptake volume (GC SUVmean) was calculated as the weighted average of SUVmean using axial images surface area. The GC SUVmean were analyzed based on the site of lung lesions: the upper half of the right lung, the lower half of the right lung, the upper half of the left lung and the lower half of the left lung.

Results: The GC SUVmean was increased significantly following RT in patients with left lung lesions (51.27% increase in lower left lung lesions with P-value=0.002, and 25.01% increase in upper left lung lesions with P-value=0.02). However, there was no significant change in GC SUVmean in those with right lung lesions. Conclusions: The average increase in the GC SUVmean in patients with left lower lung lesions was significantly greater than that in patients with left upper or right lung lesions. Therefore, in our study, the most radiation-induced cardiotoxicity was seen in patients with left lower lung lesions. These findings may be useful to consider in RT treatment planning, and also suggest the need for closer cardiac monitoring post-RT in this group of patients.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 60, Issue supplement 1
May 1, 2019
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Utilizing FDG-PET/CT to Assess Radiation-induced Cardiotoxicity in Patients with Lung Cancer Based on Tumor Location
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Utilizing FDG-PET/CT to Assess Radiation-induced Cardiotoxicity in Patients with Lung Cancer Based on Tumor Location
Raheleh Taghvaei, Reza Sirous, Alexandra Dreyfuss, Thomas Werner, Abass Alavi
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1314;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Utilizing FDG-PET/CT to Assess Radiation-induced Cardiotoxicity in Patients with Lung Cancer Based on Tumor Location
Raheleh Taghvaei, Reza Sirous, Alexandra Dreyfuss, Thomas Werner, Abass Alavi
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1314;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic & Translational

  • TIM3-targeted combined-modality radioimmunotherapy in hepatocellular carcinoma
  • Al18F-labeled á-MSH peptide derivative for early detection of melanoma
  • Combination of 177Lu-lilotomab satetraxetan with rituximab synergistically improves in-vivo therapeutic efficacy in a rituximab-resistant non-Hodgkin lymphoma (NHL) model
Show more Oncology: Basic & Translational

Image-Guided Therapy Posters

  • Do we still need to assess for lung shunt in all Y90 Liver treatment’s ?
  • Randomized Phase 3 Trial of 68Ga-PSMA-11 PET/CT Molecular Imaging for Prostate Cancer Salvage Radiotherapy Planning [PSMA-SRT]: Study Protocol
  • Imaging and therapeutic efficacy of 64Cu-labeled melanin nanoparticles in A431 tumor-bearing nude mouse models
Show more Image-Guided Therapy Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire